Related Experiment Videos
Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma
Pediatrics
|July 1, 1978
Summary
Urinary metabolite patterns in children with neuroblastoma can predict prognosis. Specific ratios like vanilmandelic acid (VMA)/homovanillic acid (HVA) and the presence of vanillactic acid are key indicators of disease severity.
Area of Science:
- Biochemistry
- Pediatric Oncology
- Metabolomics
Background:
- Neuroblastoma is a common childhood cancer.
- Prognostic factors like age and stage are crucial for treatment decisions.
- Urinary catecholamine metabolites offer insights into neuroblastoma biology.
Purpose of the Study:
- To investigate the relationship between urinary catecholamine metabolites, amino acids, and neuroblastoma prognosis.
- To identify biochemical markers that predict patient outcomes.
- To explore the link between tumor biochemical characteristics and clinical behavior.
Main Methods:
- Analysis of urinary catecholamine metabolites (VMA, HVA) and amino acids in 54 children with neuroblastoma.
- Correlation of metabolite levels and ratios with clinical prognostic factors (age, stage, site, grade).
- Statistical analysis to determine independent prognostic variables and marker significance.
Main Results:
- Age and stage were independent prognostic variables.
- The urinary VMA/HVA ratio correlated with prognosis in disseminated disease.
- Presence of vanillactic acid, increased cystathionine, and low VMA levels indicated a poor prognosis.
- Biochemically primitive tumors showed higher virulence.
Conclusions:
- Urinary metabolite profiles can serve as valuable prognostic indicators in neuroblastoma.
- Specific metabolites and their ratios may reflect tumor aggressiveness and differentiation.
- Findings support the hypothesis linking biochemical immaturity to increased neuroblastoma virulence.